Specialty Sales, which provides products and services to help prevent hoof disease among dairy farm herds, is set to become a $10m-plus EBITDA platform.
Proterra Investment Partners' Asia arm has grown to the point where it accounts for most of the firm’s AUM and is the focus for the firm’s future growth.